Bidda Sovereign Intelligence · 10,085 Verified Nodes · 39 Sovereign Pillars

Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use - Article 79

This article establishes the European Commission's authority to conduct controls to verify Member State supervision and the compliance of non-EU clinical…

What Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use - Article 79 requires

This article establishes the European Commission's authority to conduct controls to verify Member State supervision and the compliance of non-EU clinical trial regulatory systems, requiring cooperation and the reporting of findings via the EU portal.

Pillar: Biotech & Genomics · Authority: European Parliament and Council of the European Union · Version: 1.0.0 · Last updated:

Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32014R0536

SHA-256 integrity: a71e105e3094b46e340ab44e7fe2835768f9823b4fd839565782262af5af0101

Primary Citations — 5 traced to source

  • Article 79, paragraph 1: The Commission may conduct controls in order to verify: (a) whether Member States correctly supervise compliance with this Regulation;
  • Article 79, paragraph 1(b): ...whether the regulatory system applicable to clinical trials conducted outside the Union ensures that point 8 of the Introduction and general principles contained in Annex I to Directive 2001/83/EC is complied with;

+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.

Access

⚠ Important: Human Verification Required

Bidda compliance nodes are reference intelligence, not legal advice. Every node must be reviewed by a qualified compliance professional or legal counsel before implementation in any enterprise workflow, regulated system, or compliance programme. See bidda.com/disclaimer for full terms.